Series D Medical Companies

Wandercraft develops autonomous walking exoskeletons designed to restore upright mobility to individuals with walking impairments.

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

Spyglass Pharma provides medicine for ophthalmic diseases.

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

GT Medical Technologies is a medical device company that offers innovative medical solutions for brain tumor patients.

Ossio is an orthopedic medical device company.

Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.

CSA Medical is a provider of innovative spray cryotherapy medical device solutions.

Medical device company that aims to Prevent Aspiration Pneumonia, VAP and Acute Kidney Injury in critical care patients

Neptune Medical is a medical device company that develops endoscopic and surgical devices.

Moximed develops innovative therapies for patients with knee osteoarthritis.

Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Eko Health is a digital health company providing digital stethoscopes and an AI detection platform for diagnosing heart and lung diseases.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.

Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories.

ViCentra has developed an insulin pump for diabetes patients.

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

Oviva offers digital solutions for treating diabetes and obesity using a platform focused on behavior change.